{
    "2021-08-29": [
        [
            {
                "time": "2021-08-29",
                "original_text": "为何重组蛋白新冠疫苗保护率甚高？【东吴医药朱国广团队|0829周报】",
                "features": {
                    "keywords": [
                        "重组蛋白",
                        "新冠疫苗",
                        "保护率",
                        "东吴医药",
                        "朱国广团队"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}